Novartis loses patent battle in India: Time to realign the business model to emerging markets?

On April 1, 2013, the Supreme Court of India rejected Novartis’ patent application for its cancer treatment drug, Glivec. Novartis had applied for patent protection in 2006, and after a seven-year legal battle, it all ended in disappointment for the Swiss pharmaceutical company. Public opinion seeme...

Full description

Saved in:
Bibliographic Details
Main Authors: REDDY, Srinivas K., LLEWELYN, David, MATHUR, Sarita
Format: text
Language:English
Published: Institutional Knowledge at Singapore Management University 2013
Subjects:
IP
Online Access:https://ink.library.smu.edu.sg/cases_coll_all/54
https://cmp.smu.edu.sg/case/2601
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Singapore Management University
Language: English